Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Name Change, Merge, and Reorganization of the Clinician-Administered Drugs Handbook and Appendix B: Vendor Drug Program in the TMPPM

Last updated on

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to eligible clients. Administrative procedures such as prior authorization, pre-certification, referrals, and claims/encounter data filing may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the client's specific MCO for details.

Beginning September 1, 2020, the Texas Medicaid Provider Procedures Manual (TMPPM) Clinician-Administered Drugs Handbook will be renamed Outpatient Drug Services Handbook. Additionally, the contents of Appendix B: Vendor Drug Program, currently located in Volume 1 of the TMPPM, will be merged into the renamed handbook.

The following changes will also be incorporated in the Outpatient Drug Services Handbook:

  • Some tables will be reformatted and some sections will be reorganized.
  • The CAD injections table will be removed, and a section will be created for each injection that is not currently in an existing section.
  • Standard prior authorization language will be removed from some sections and a general prior authorization section will be created.

The following new information will be added to the Outpatient Drug Services Handbook:

  • Pharmacy manufacturer information and instructions
  • Retrospective Drug Utilization Reviews

For more information, call the TMHP Contact Center at 800-925-9126.